U.S. Carotid Artery Stents Market Revenue & Forecast Analysis, 2026-2035

The U.S. carotid artery stents market was evaluated at USD 212.33 million in 2025 and is projected to grow at a CAGR of 4.0% from USD 219.35 million in 2026 to USD 311.11 million in 2035. The robust market expansion is primarily driven by the rising prevalence of carotid artery stenosis and ischemic stroke, coupled with the growing geriatric population that is at a higher risk of developing vascular diseases. Additionally, advancements in carotid stent technologies, increasing adoption of minimally invasive treatment procedures, and expanding awareness regarding stroke prevention are supporting the growth of the U.S. carotid artery stents market.

Published: June 22, 2026
100 Pages

Market Overview

According to a 2025 study examining Medicare beneficiaries, 395,092 carotid revascularisation procedures were performed in the United States between 2017 and 2024, reflecting the substantial patient population requiring treatment for carotid artery stenosis and supporting the demand for carotid artery stenting technologies.

The U.S. carotid artery stents market has expanded steadily over time, driven by improvements in endovascular intervention techniques, growing clinical evidence supporting carotid artery stenting in appropriately selected patients, and increasing availability of advanced neuroprotection systems during procedures. The market has also benefited from favorable reimbursement coverage, rising utilisation of outpatient vascular care services, and the expansion of specialised stroke and vascular treatment centers across the country. For instance, in September 2023, the Centers for Medicare & Medicaid Services (CMS) expanded Medicare coverage for carotid artery stenting to include a broader group of patients, improving access to minimally invasive carotid revascularisation procedures and supporting market growth.

The U.S. carotid artery stents market is projected to experience significant growth throughout the forecast period due to the increasing emphasis on early detection of carotid artery disease, expanding screening initiatives among high-risk populations, and ongoing improvements in vascular imaging technologies. The growing integration of advanced diagnostic platforms and enhanced physician training in endovascular interventions is also contributing to market expansion. For instance, by 2035, healthcare providers across the U.S. are expected to increase the adoption of next-generation carotid stent systems to improve procedural efficiency and patient outcomes.

U.S. Carotid Artery Stents Market Overview

Base Year Market Size (2025): USD 212.33 Million

CAGR: 4.0%

Forecast Year Market Size (2035): USD 311.11 Million

Major Players:

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Medtronic plc

  • Terumo Corporation

  • Silk Road Medical, Inc.

U.S. Carotid Artery Stents Market Trends

The U.S. carotid artery stents market is evolving rapidly due to the increasing focus on personalised vascular care, procedural optimisation, and the adoption of innovative treatment planning approaches.

  • The rising adoption of transcarotid artery revascularization (TCAR) procedures is improving access options for patients requiring carotid revascularization.

  • The growing demand for dual-layer and mesh-covered stent designs is supporting efforts to enhance plaque coverage and procedural performance.

  • The increasing utilization of real-world evidence and post-market clinical registries is helping physicians evaluate long-term outcomes and treatment effectiveness.

  • The expansion of integrated care pathways for carotid artery disease management is improving coordination across diagnosis, intervention, and follow-up care.

Collectively, these trends are expected to support the continued growth of the U.S. carotid artery stents market by enhancing treatment precision, supporting evidence-based care, and improving overall procedural outcomes.

U.S. Carotid Artery Stents Market Analysis

By Material Type

Metals dominate the U.S. carotid artery stents market due to their widespread clinical use

Based on the material type, the U.S. carotid artery stents market is categorised into metals and polymers. The metals segment leads the market with the highest market share in 2025.

By Mode of Delivery

Balloon-expandable stents dominate the U.S. carotid artery stents market owing to their precise deployment capabilities

Based on the mode of delivery, the U.S. carotid artery stents market is categorised into balloon-expandable stents and self-expanding stents. The balloon-expandable stents segment leads the market with the highest market share in 2025.

By Application

Symptomatic carotid artery stenosis dominates the U.S. carotid artery stents market due to higher treatment demand

Based on the application, the U.S. carotid artery stents market is categorised into symptomatic carotid artery stenosis, asymptomatic carotid artery stenosis, and post-CEA restenosis. The symptomatic carotid artery stenosis segment leads the market with the highest market share in 2025.

By End-use

Hospitals dominate the U.S. carotid artery stents market due to high procedure volumes.

Based on the end-use, the U.S. carotid artery stents market is categorised into hospitals, ambulatory surgical centers, and others. The hospitals segment leads the market with the highest market share in 2025.

Key Companies Profiled

The U.S. carotid artery stents market features a competitive landscape with leading cardiovascular and vascular device companies competing through carotid stent systems, embolic protection devices, and transcarotid revascularisation technologies. Key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and Silk Road Medical, Inc. hold a significant share of the market, supported by established product portfolios, strong physician relationships, and ongoing technological advancements.

The market is highly competitive, with companies focusing on stent design improvements, procedural safety enhancements, and clinical evidence generation to strengthen their market positions. The growing demand for carotid revascularisation procedures, expanding patient eligibility, and increasing emphasis on stroke risk reduction are further intensifying competition across the U.S. healthcare system. For instance, in 2025, Terumo Corporation received U.S. FDA approval for its ROADSAVER™ Carotid Stent System, reinforcing competition in the carotid artery stents market.

U.S. Carotid Artery Stents Market Companies:

Some of the key companies operating in the U.S. Carotid Artery Stents Market include:

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Contego Medical, Inc.

  • Cook Medical

  • Cordis Corporation

  • InspireMD, Inc.

  • Johnson & Johnson MedTech (Cerenovus)

  • LeMaitre Vascular, Inc.

  • Medtronic plc

  • Merit Medical Systems, Inc.

  • Penumbra, Inc.

  • Silk Road Medical, Inc.

  • Stryker Corporation

  • Terumo Neuro

  • W. L. Gore & Associates, Inc.

Market Segmentation

This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. carotid artery stents market by-

Material Type (Revenue in USD Million, 2021 - 2035)

  • Metals

    • Stainless Steel

    • Nitinol

    • Cobalt Chromium

    • Others

  • Polymers

Mode of Delivery (Revenue in USD Million, 2021 - 2035)

  • Balloon-expandable Stents

  • Self-expanding Stents

Application (Revenue in USD Million, 2021 - 2035)

  • Symptomatic Carotid Artery Stenosis

  • Asymptomatic Carotid Artery Stenosis

  • Post-CEA restenosis

End-use (Revenue in USD Million, 2021 – 2035)

  • Hospitals

  • Ambulatory Surgical Centers

  • Others

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Value Chain Analysis

3.5. Technology Roadmap

3.6. Porters Analysis

3.7. PESTLE Analysis

4. Market Estimates and Forecasts, By Material Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Metals

4.1.1. Stainless Steel

4.1.2. Nitinol

4.1.3. Cobalt Chromium

4.1.4. Others

4.2. Polymers

5. Market Estimates and Forecasts, By Mode of Delivery, 2021 - 2035 (Market Size in USD Mn)

5.1. Balloon-expandable Stents

5.2. Self-expanding Stents

6. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

6.1. Symptomatic Carotid Artery Stenosis

6.2. Asymptomatic Carotid Artery Stenosis

6.3. Post-CEA restenosis

7. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

7.1. Hospitals

7.2. Ambulatory Surgical Centers

7.3. Others

8. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)

8.1.1. U.S.

8.1.1.1. U.S. Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.1.1.2. Market Dynamics

8.1.1.3. Competitive Landscape

8.1.1.4. Regulatory Framework

8.1.1.5. Reimbursement Scenario

9. Competitive Landscape

9.1. Company Market Share Analysis, 2025

9.2. Company Tier Structure

9.3. List of Major Suppliers, By Key Countries

9.4. Key Company Positioning Analysis

9.5. Company Profile

9.5.1. Abbott Laboratories

9.5.2. Boston Scientific Corporation

9.5.3. Contego Medical, Inc.

9.5.4. Cook Medical

9.5.5. Cordis Corporation

9.5.6. InspireMD, Inc.

9.5.7. Johnson & Johnson MedTech (Cerenovus)

9.5.8. LeMaitre Vascular, Inc.

9.5.9. Medtronic plc

9.5.10. Merit Medical Systems, Inc.

9.5.11. Penumbra, Inc.

9.5.12. Silk Road Medical, Inc.

9.5.13. Stryker Corporation

9.5.14. Terumo Neuro

9.5.15. W. L. Gore & Associates, Inc.

10. Analyst Perspective

11. Related Reports

Related Research

Blood Clot Retrieval Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Radiofrequency Skin Rejuvenation Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Plaque Modification Devices Market Revenue & Forecast Analysis, 2026-2035

July 13, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.